MLXIPL and Insulin resistance: In contrast with the aforementioned studies that show that liver-specific knockout or knockdown of ChREBP protects against obesity and insulin resistance, Jois et al. (81) reported that liver-specific ChREBP knockout exacerbates hepatic insulin resistance on both chow and high-fat diets without effects on body weight.